Diagnos Inc.
ADK.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -47.75% | -50.04% | -48.63% | -40.68% | -35.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -47.75% | -50.04% | -48.63% | -40.68% | -35.90% |
| Cost of Revenue | 46.90% | 41.07% | 38.88% | 0.41% | 4.24% |
| Gross Profit | -60.76% | -58.60% | -57.79% | -8.74% | -14.80% |
| SG&A Expenses | 26.22% | 50.50% | 65.17% | 56.97% | 24.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 32.44% | 47.46% | 56.24% | 36.44% | 17.91% |
| Operating Income | -35.64% | -52.79% | -62.97% | -41.47% | -22.02% |
| Income Before Tax | -22.92% | -37.82% | -47.09% | -32.65% | -21.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -22.92% | -37.82% | -47.09% | -32.65% | -21.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.92% | -37.82% | -47.09% | -32.65% | -21.50% |
| EBIT | -35.64% | -52.79% | -62.97% | -41.47% | -22.02% |
| EBITDA | -37.73% | -54.97% | -65.65% | -43.07% | -22.91% |
| EPS Basic | 2.42% | -7.19% | -16.34% | -8.18% | -4.76% |
| Normalized Basic EPS | 2.90% | -7.50% | -16.75% | -9.09% | -5.61% |
| EPS Diluted | 2.42% | -7.19% | -16.34% | -8.18% | -4.76% |
| Normalized Diluted EPS | 2.90% | -7.50% | -16.75% | -9.09% | -5.61% |
| Average Basic Shares Outstanding | 27.81% | 28.74% | 26.42% | 21.17% | 14.85% |
| Average Diluted Shares Outstanding | 27.81% | 28.74% | 26.42% | 21.17% | 14.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |